The Effect of Maternal Antioxidant Vitamin Supplementation on Maternal and Cord Blood Adiponectin Concentrations

Abstract

Objective

Adiponectin is a hormone that modulates glucose regulation and fatty acid oxidation. Low adiponectin concentration has been associated with increased insulin resistance. Studies show a beneficial effect of vitamin E supplementation on insulin sensitivity. We aimed to investigate the association of prenatal antioxidant supplementation with increased adiponectin concentrations in pregnant participants and their newborn infants.

Study Design

Secondary analysis of a randomized control trial of prenatal vitamin C and E supplementation to prevent preeclampsia in low-risk nulliparous participants. Plasma of participants at time of randomization (9–16 weeks gestation) and delivery, and neonatal cord blood were analyzed by specific enzyme-linked immunosorbent assay for adiponectin concentration. Multivariable analysis was adjusted for confounders.

Results

A total of 198 (98 vitamin, 100 placebo) maternal–neonatal dyad samples were analyzed. Maternal and neonatal characteristics were similar between the vitamin and placebo groups, with the exception of race/ethnicity, with Whites more common in the placebo group (80 vs. 66.3%, p = 0.02). In bivariable analyses, adiponectin concentrations at delivery were higher in the vitamin group compared with the placebo group (29.4 vs. 27.5 µg/mL, p = 0.04), whereas cord blood adiponectin concentrations were similar (26.6 . vs. 27.4 µg/mL, p = 0.47) between the two groups. There was a significant interaction between treatment group and maternal baseline adiponectin level on the adiponectin concentrations at delivery (p = 0.04) and cord blood adiponectin (p < 0.05). For participants whose baseline adiponectin concentrations were in the highest tertile, vitamin supplementation was associated with higher adiponectin concentrations at delivery. However, for participants whose baseline adiponectin concentration were in the lowest tertile, vitamin supplementation was associated with lower cord blood adiponectin concentrations.

Conclusion

For participants with high baseline adiponectin concentration, vitamin C and E supplementation is associated with higher adiponectin concentration at delivery. Conversely, vitamin supplementation is associated with lower cord adiponectin concentration among participants with low baseline adiponectin concentration.

Key Points

• Vitamin E is an antioxidant with metabolic properties.

• Adiponectin is a cytokine with metabolic properties.

• Vitamin E is associated with higher pregnancy adiponectin.

• Vitamin E is associated with lower neonatal adiponectin.

• Vitamin E correlated with positive pregnancy and neonatal adiponectin trends.

Keywords

neonate - adiponectin - vitamin C and E - antioxidant

Publication History

Received: 01 December 2023

Accepted: 31 December 2024

Article published online:
06 March 2025

• References

• 1 Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. Vitamin E as a potential interventional treatment for metabolic syndrome: evidence from animal and human studies. Front Pharmacol 2017; 8: 444
• 2 Asbaghi O, Choghakhori R, Abbasnezhad A. Effect of omega-3 and vitamin E co-supplementation on serum lipids concentrations in overweight patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2019; 13 (04) 2525-2531
• 3 Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57 (05) 650-656
• 4 Paolisso G, Di Maro G, Galzerano D. et al. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994; 59 (06) 1291-1296
• 5 Salonen JT, Nyyssönen K, Tuomainen TP. et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 1995; 311 (7013) 1124-1127
• 6 Ley SH, Hanley AJ, Sermer M, Zinman B, O'Connor DL. Lower dietary vitamin E intake during the second trimester is associated with insulin resistance and hyperglycemia later in pregnancy. Eur J Clin Nutr 2013; 67 (11) 1154-1156
• 7 Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr 1997; 127 (01) 103-107
• 8 Laight DW, Desai KM, Gopaul NK, Anggård EE, Carrier MJ. F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur J Pharmacol 1999; 377 (01) 89-92
• 9 Paz K, Hemi R, LeRoith D. et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997; 272 (47) 29911-29918
• 10 Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23 (05) 599-622
• 11 Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005; 7 (7-8): 1040-1052
• 12 Looman M, Schoenaker DAJM, Soedamah-Muthu SS, Mishra GD, Geelen A, Feskens EJM. Pre-pregnancy dietary micronutrient adequacy is associated with lower risk of developing gestational diabetes in Australian women. Nutr Res 2019; 62: 32-40
• 13 Parast VM, Paknahad Z. Antioxidant status and risk of gestational diabetes mellitus: a case control study. Clin Nutr Res 2017; 6 (02) 81-88
• 14 Landrier J-F, Gouranton E, El Yazidi C. et al. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor γ-dependent mechanism. Endocrinology 2009; 150 (12) 5318-5325
• 15 Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116 (07) 1784-1792
• 16 Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol 2016; 8 (02) 93-100
• 17 Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003; 26 (08) 2442-2450
• 18 Xita N, Tsatsoulis A. Adiponectin in diabetes mellitus. Curr Med Chem 2012; 19 (32) 5451-5458
• 19 Geagea AG, Mallat S, Matar CF. et al. Adiponectin in health and disease: an update. Open Med 2018; 5: 20-32
• 20 Catalano PM, Hoegh M, Minium J. et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49 (07) 1677-1685
• 21 Madhu SV, Bhardwaj S, Jhamb R, Srivastava H, Sharma S, Raizada N. Prediction of gestational diabetes from first trimester serum adiponectin levels in Indian women. Indian J Endocrinol Metab 2019; 23 (05) 536-539
• 22 Iwaki M, Matsuda M, Maeda N. et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52 (07) 1655-1663
• 23 Combs TP, Wagner JA, Berger J. et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002; 143 (03) 998-1007
• 24 Ramezani A, Koohdani F, Djazayeri A. et al. Effects of administration of omega-3 fatty acids with or without vitamin E supplementation on adiponectin gene expression in PBMCs and serum adiponectin and adipocyte fatty acid-binding protein levels in male patients with CAD. Anatol J Cardiol 2015; 15 (12) 981-989
• 25 Debier C. Vitamin E during pre- and postnatal periods. Vitam Horm 2007; 76: 357-373
• 26 Ashworth CJ, Antipatis C. Micronutrient programming of development throughout gestation. Reproduction 2001; 122 (04) 527-535
• 27 Kaempf-Rotzoll DE, Horiguchi M, Hashiguchi K. et al. Human placental trophoblast cells express α-tocopherol transfer protein. Placenta 2003; 24 (05) 439-444
• 28 Roberts JM, Myatt L, Spong CY. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010; 362 (14) 1282-1291
• 29 Arita Y, Kihara S, Ouchi N. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257 (01) 79-83
• 30 Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A. Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 2004; 56 (05) 690-693
• 31 Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol (Oxf) 2004; 61 (04) 418-423
• 32 Mazaki-Tovi S, Kanety H, Pariente C. et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol 2007; 27 (02) 77-81
• 33 Luo ZC, Nuyt AM, Delvin E. et al. Maternal and fetal leptin, adiponectin levels and associations with fetal insulin sensitivity. Obesity (Silver Spring) 2013; 21 (01) 210-216
• 34 Chan TF, Yuan SS, Chen HS. et al. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand 2004; 83 (02) 165-169
• 35 Weyermann M, Beermann C, Brenner H, Rothenbacher D. Adiponectin and leptin in maternal serum, cord blood, and breast milk. Clin Chem 2006; 52 (11) 2095-2102
• 36 Cortelazzi D, Corbetta S, Ronzoni S. et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007; 66 (03) 447-453
• 37 Rasool AH, Yuen KH, Yusoff K, Wong AR, Rahman AR. Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol (Tokyo) 2006; 52 (06) 473-478
• 38 Landrier JF, Kasiri E, Karkeni E. et al. Reduced adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1 and further retinoic acid receptor signaling in adipose tissue. FASEB J 2017; 31 (01) 203-211
• 39 Du Q, Luo ZC, Nuyt AM. et al. Vitamin A and E nutritional status in relation to leptin, adiponectin, IGF-I and IGF-II in early life—a birth cohort study. Sci Rep 2018; 8 (01) 100
• 40 Haghiac M, Basu S, Presley L, Serre D, Catalano PM, Hauguel-de Mouzon S. Patterns of adiponectin expression in term pregnancy: impact of obesity. J Clin Endocrinol Metab 2014; 99 (09) 3427-3434
• 41 López-Bermejo A, Fernández-Real JM, Garrido E. et al. Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight. Clin Endocrinol (Oxf) 2004; 61 (05) 544-552
• 42 Zhang ZQ, Lu QG, Huang J, Jiao CY, Huang SM, Mao LM. Maternal and cord blood adiponectin levels in relation to post-natal body size in infants in the first year of life: a prospective study. BMC Pregnancy Childbirth 2016; 16 (01) 189
• 43 Basu S, Laffineuse L, Presley L, Minium J, Catalano PM, Hauguel-de Mouzon S. In utero gender dimorphism of adiponectin reflects insulin sensitivity and adiposity of the fetus. Obesity (Silver Spring) 2009; 17 (06) 1144-1149